Individuals with cardiometabolic risk factors are at higher risk for early-onset NAFLD

Study concept and design: Tianshu Zeng, Wenkong, and Linfeng He; Statistical analysis and interpretation: Linfeng He; Data acquisition and validation: Wenbin Zheng and Yunfei Liao; All authors wrote and approved final manuscripts. A multisociety Delphi consensus statement on new fatty liver disease nomenclatureJournal of HepatologyVol. 79Issue 6PreviewThe principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favour of a change in nomenclature and/or definition. A modified Delphi process was led by three large pan-national liver associations. The consensus was defined a priori as a supermajority (67%) vote. An independent committee of experts external to the nomenclature process made the final recommendation on the acronym and its diagnostic criteria. Full-Text PDF Open Access